Lilly appeals retatrutide classification ruling in case that could impact compoundersnews2026-02-13T17:31:04+00:00February 13th, 2026|Endpoints News|
Medtronic receives FDA clearance for Stealth AXiS™ surgical system | 1st Integrated planning, navigation and robotics platform for spine surgerynews2026-02-13T15:50:23+00:00February 13th, 2026|Medical Device News Magazine|
Pharma pushes back on FDA plans to ease prescription-OTC drug switchesnews2026-02-12T18:35:50+00:00February 12th, 2026|Endpoints News|
Controversy around FDA’s Prasad rises again after Moderna rejection, behavior allegationsnews2026-02-12T16:24:16+00:00February 12th, 2026|Endpoints News|
FDA may consider Moderna’s flu vaccine in a narrower groupnews2026-02-11T21:06:04+00:00February 11th, 2026|Endpoints News|
Prasad overruled vaccine review team, office director on Moderna flu shotnews2026-02-11T16:21:58+00:00February 11th, 2026|Endpoints News|
Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point? news2026-02-11T14:21:30+00:00February 11th, 2026|Endpoints News|
Moderna accuses FDA of shifting standard as agency refuses flu shot reviewnews2026-02-10T23:00:09+00:00February 10th, 2026|Endpoints News|
NIH stops low-dose Xarelto arm of large stroke study due to safety concernsnews2026-02-10T19:55:14+00:00February 10th, 2026|Endpoints News|
FDA rejects Regenxbio’s Hunter syndrome gene therapynews2026-02-09T21:15:23+00:00February 9th, 2026|Endpoints News|
